Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06202898 · ClinicalTrials.gov registry record · NA

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

A NA study of HIV and AIDS, sponsored by University of Central Florida.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT06202898 is a NA study of HIV and AIDS that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 110 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06202898, a NA study of HIV and AIDS, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Interventions

  • OTHER Control
  • OTHER Baseline
  • OTHER ENTRUST

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-07-11
Est. Completion 2027-06
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT06202898

The ClinicalTrials.gov registry entry for NCT06202898 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (75% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT06202898 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06202898 about?

NCT06202898 is a clinical study titled "Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)". The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their A...

What is the current status of trial NCT06202898?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-07-11. Estimated completion is 2027-06.

What conditions does trial NCT06202898 study?

This clinical trial studies the following conditions: HIV, AIDS, Transgender Women.

What interventions are being tested in trial NCT06202898?

The interventions under investigation include: Control (OTHER), Baseline (OTHER), ENTRUST (OTHER).

Who is sponsoring clinical trial NCT06202898?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06202898 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.